PLCG1 and Parkinson disease: Given the vulnerability of SNc dopamine neurons in Parkinson’s disease (PD) and their premature degeneration during disease progression62,63, we hypothesized that the increased dopamine release in PLCγ1 cKO mice would attenuate the degeneration of dopamine neurons in an animal model of PD.